Cargando…
Oncolysis of malignant human melanoma tumors by Coxsackieviruses A13, A15 and A18
Many RNA viruses are displaying great promise in the field of oncolytic virotherapy. Previously, we reported that the picornavirus Coxsackievirus A21 (CVA21) possessed potent oncolytic activity against cultured malignant melanoma cells and melanoma xenografts in mice. In the present study, we demons...
Autores principales: | Au, Gough G, Beagley, Leone G, Haley, Erin S, Barry, Richard D, Shafren, Darren R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033357/ https://www.ncbi.nlm.nih.gov/pubmed/21241513 http://dx.doi.org/10.1186/1743-422X-8-22 |
Ejemplares similares
-
Combination of intravenously delivered cavatak (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and tumor rechallenge
por: Yuan, Min, et al.
Publicado: (2015) -
Combination of a novel oncolytic immunotherapeutic agent, CAVATAK (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and improves survival in an immune competent mouse melanoma model
por: Shafren, Darren, et al.
Publicado: (2014) -
Oncolytic immunotherapy for the treatment of non-muscle invasive bladder cancer using intravesical coxsackievirus A21
por: Annels, Nicola E, et al.
Publicado: (2015) -
Perspectives for Combining Viral Oncolysis With Additional Immunotherapies for the Treatment of Melanoma
por: Cerqueira, Otto Luiz Dutra, et al.
Publicado: (2022) -
Mechanisms of Oncolysis by Paramyxovirus Sendai
por: Matveeva, O. V., et al.
Publicado: (2015)